BJP RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


The British Journal of Psychiatry (2006) 189: 200. doi: 10.1192/bjp.189.2.200
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tyrer, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tyrer, P.

COLUMNS

From the Editor's desk

Peter Tyrer

NUGGETS OF GOLD

Good scientific discovery always has elements of the unexpected. When cynics describe researchers as people who `when looking for the solution of a problem, always know the answer in advance' they describe a facet of commonly executed research that is a far cry from the good studies we hope to publish in the Journal. So where are the nuggets of gold in this issue? Well, gold has three important properties for the beholder; mimicry, malleability and improbability, and illustration of all these are manifest in the earlier pages. The disproving of seductive hypotheses, the false gold of knowledge, is an important task for the good scientist, but is proving more difficult at a time when big combines and pressure groups have usurped the role of expert, and scientists are finding it more difficult to defend their corner.

Debunking outmoded theories therefore has to become more strident. So herewith our megaphone messages: aripiprazole has no special attributes as an atypical antipsychotic (El-Sayeh et al, pp. 102-108); counselling is a total waste of time for post-traumatic stress disorder (Sijbrandij et al, pp. 150-155) with only cognitive-behavioural treatment showing any benefit (Bisson et al, 2004; Turpin et al, 2005); post-traumatic stress disorder is determined more by pre-trauma pathology than by the trauma itself (Dirkzwager et al, pp. 144-149); we consume more psychotropic drugs but at no gain to overall mental health (Colman et al, pp. 156-160; Helgason et al, 2004), and schizophrenia is a neurological disease in which impaired memory is almost universal (Al-Uzri et al, pp. 132-136; Joyce et al, 2005). This will not be enough to dull the glitter of the alternative falsehoods reflecting off iron pyrites, but they will help to redress the balance.

The malleability of gold, the ability of the element to be fashioned into almost any shape, is also the mark of good scientific knowledge; it should be universally applicable. The messages here are: beware the dangers of effective antidepressants as mood switchers in bipolar disorder (Post et al, pp. 124-131); and depression persists even though its diagnosis comes and goes (Paykel et al, pp. 118-123), further illustrating that our diagnostic boundaries are really quite arbitrary. The improbability factor, the capacity of gold to amaze and astound (the Au effect) astound (the Au effect) is best shown by shown by our case report of a patient with panic attacks and subsequent delusions (Parthasarathi et al, pp. 182-183). I have always suspected that patients with rapid and dramatic changes in phenomenology have an organic syndrome but voltage-gated potassium channel antibody-associated encephalopathy really gets the gold medal for differential diagnosis.

CLIMBING THE FOOTHILLS OF THE IMPACT FACTOR PEAKS

Grumbles abound with the preoccupation many authors and institutions have with the impact factor of scientific journals and with the alleged superiority of those with higher scores (Barbui et al, 2006). At the college where I work we are exhorted to submit our papers regularly to journals such as Lancet or Nature even when we regard this as a waste of the Editor's time. However, as a former editor of the Lancet once advised me, if you have a novel paper on a condition in which all its international experts are authors (preferably more than 50), and it also has the advantage of being totally unreadable, then the Lancet or a similar top-line journal is the place for you. You (and your greedy institution) will now be rewarded with an impact factor of 44.02 if you manage to scale the Everest of the New England Journal of Medicine, with a K2 score of 23.41 for the Lancet. For those lesser souls scrambling among the foothills the British Journal of Psychiatry is a good hike at 4.96 (the highest impact factor we have yet attained) and only the Journal of Clinical Psychiatry (5.04), American Journal of Psychiatry (8.29) and Archives of General Psychiatry (12.64) of the general psychiatric journals offer stiffer climbs. It is more satisfying to note that our own improvement has happened in spite of going against the advice generally given in order to improve our ranking (Howard & Wilkinson, 1997). We have not published more reviews, reduced the numbers of articles (they are now increased with short reports), or tilted the balance towards biological research. More importantly, I hope we have not become less readable - but that is for you to judge. My thanks to all our editors, reviewers and journal staff for adding to our stature, if indeed this landscape is more than a mirage.

REFERENCES

Barbui, C., Cipriani, A. Malvini, L., et al (2006) Validity of the impact factor of journals as a measure of randomized controlled trial quality. Journal of Clinical Psychiatry, 67, 37 -40.

Bisson, J. I., Shepherd, J. P., Joy, D., et al (2004) Early cognitive-behavioural therapy for post-traumatic stress symptoms after physical injury: randomised controlled trial. British Journal of Psychiatry, 184, 63-69.[Abstract/Free Full Text]

Helgason, T., Tomasson, H. & Zoega, T. (2004) Antidepressants and public health in Iceland: time series analysis of national data. British Journal of Psychiatry, 184, 157 -162.[Abstract/Free Full Text]

Howard, L. & Wilkinson, G. (1997) Impact factors of psychiatric journals. British Journal of Psychiatry, 170, 109 -112.[Abstract/Free Full Text]

Joyce, E. M., Hutton, S. B., Mutsatsa, S. H., et al (2005) Cognitive heterogeneity in first-episode schizophrenia. British Journal of Psychiatry, 187, 516 -522.[Abstract/Free Full Text]

Turpin, G., Downs, M. & Mason, S. (2005) Effectiveness of providing self-help information following acute traumatic injury: randomised controlled trial. British Journal of Psychiatry, 187, 76 -82.[Abstract/Free Full Text]


Related articles in BJP:

Aripiprazole for schizophrenia: Systematic review
H. G. El-Sayeh, C. Morganti, and C. E. Adams
BJP 2006 189: 102-108. [Abstract] [Full Text]  

Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder
Eugene S. Paykel, Rosemary Abbott, Richard Morriss, Hazel Hayhurst, and Jan Scott
BJP 2006 189: 118-123. [Abstract] [Full Text]  

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline
R. M. Post, L. L. Altshuler, G. S. Leverich, M. A. Frye, W. A. Nolen, R. W. Kupka, T. Suppes, S. McElroy, P. E. Keck, K. D. Denicoff, H. Grunze, J. Walden, C. M. R. Kitchen, and J. Mintz
BJP 2006 189: 124-131. [Abstract] [Full Text]  

Measuring memory impairment in community-based patients with schizophrenia: Case-control study
M. M. Al-Uzri, M. A. Reveley, L. Owen, J. Bruce, S. Frost, D. Mackintosh, and P. M. Moran
BJP 2006 189: 132-136. [Abstract] [Full Text]  

Risk factors for psychological and physical health problems after a man-made disaster: Prospective study
Anja J. E. Dirkzwager, Linda Grievink, Peter G. Van der Velden, and C. Joris Yzermans
BJP 2006 189: 144-149. [Abstract] [Full Text]  

Emotional or educational debriefing after psychological trauma: Randomised controlled trial
Marit Sijbrandij, Miranda Olff, Johannes B. Reitsma, Ingrid V. E. Carlier, and Berthold P. R. Gersons
BJP 2006 189: 150-155. [Abstract] [Full Text]  

Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort
Ian Colman, Michael E. J. Wadsworth, Tim J. Croudace, and Peter B. Jones
BJP 2006 189: 156-160. [Abstract] [Full Text]  

Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy: Case report
U. D. Parthasarathi, T. Harrower, M. Tempest, J. R. Hodges, C. Walsh, P. J. McKenna, and P. C. Fletcher
BJP 2006 189: 182-183. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tyrer, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tyrer, P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals